LUNAC Therapeutics
LUNAC Therapeutics develops advanced anticoagulants targeting activated Factor XII.
Filter & sort
Recently funded companies in the UK tech ecosystem.
LUNAC Therapeutics develops advanced anticoagulants targeting activated Factor XII.
Laverock Therapeutics develops a gene silencing platform for programmable advanced therapies.

Lightcast Discovery builds a novel single-cell functional analysis platform for life science research.
Lindus Health operates a technology platform to run faster end-to-end clinical trials.
MIP Diagnostics develops synthetic antibodies for use in diagnostic devices.
MIP Discovery develops synthetic affinity reagents for cell and gene therapies.

Magnitude Biosciences provides nematode worm testing services to accelerate preclinical drug discovery for biotech firms.